Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innocoll Biotherapeutics
Athlone, Irelandinnocoll.com ↗
- Ownership
- Private
- Employees
- ~78
- Development stage
- Other
01
Overview
Commercial-stage company with FDA-approved products XARACOLL and POSIMIR for postsurgical pain management; previously advanced COGENZIA and COLLAGUARD to late-stage but outcomes unclear.
- Therapeutic areas
- NeurologyOtherInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
DURECT CorporationPhytopharm PLCTakedaEUSA PharmaPioneerBiomet 3iBiomet
Beyond the preview
Go deeper on Innocoll Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innocoll Biotherapeutics.